Business Wire

Lattice Launches Industry-First PQC-Ready FPGA Family: MachXO5-NX TDQ

Share

Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today introduced the Lattice MachXO5™-NX TDQ family, the industry’s first secure control FPGAs with full Commercial National Security Algorithm (CNSA) 2.0-compliant post-quantum cryptography (PQC) support. Built on the award-winning Lattice Nexus™ platform, MachXO5-NX TDQ FPGAs deliver unmatched security, reliability, and flexibility for Computing, Communications, Industrial, and Automotive applications as the threat of quantum-enabled cyberattacks rises.

“Quantum computing advances increase the urgency to adopt quantum-resistant security across every industry,” said Esam Elashmawi, Chief Strategy and Marketing officer, Lattice Semiconductor. “With MachXO5-NX TDQ, Lattice is first to market with a secure control FPGA family that not only meets today’s security mandates but also delivers crypto-agility and hardware root of trust to future-proof our customers’ infrastructure against evolving threats.”

The Lattice MachXO5-NX TDQ FPGA family equips customers with:

  • Full Suite of CNSA 2.0 Compliant PQC
    • First and only complete CNSA 2.0 and National Institute of Standards and Technology (NIST)-approved PQC algorithms (LMS, XMSS, ML-DSA, ML-KEM, AES256-GCM, SHA2, SHA3, SHAKE) for robust protection against quantum threats
    • Authenticated and/or encrypted bitstream ensuring data integrity and protection against unauthorized access with ML-DSA, LMS, XMSS, AES256
    • Unique, patent pending crypto-agility with in-field algorithm update capability and anti-rollback version protection to enable ongoing alignment with evolving standards
    • Secure bitstream key management with revokable root keys and sophisticated key hierarchy for both PQC and classical keys
  • Advanced Cryptography
    • Full complement of advanced symmetric and classical asymmetric cryptographic algorithms (AES-CBC/GCM 256 bit, ECDSA-384/521, SHA-384/512, RSA 3072/4096 bit) for bitstream and user data protection
    • Device Identifier Composition Engine (DICE), Security Protocol and Data Model (SPDM), and Lattice SupplyGuard™ capable, providing attestation and secure lifecycle/supply chain management for future-proof, end-to-end security
  • Hardware Root of Trust (RoT)
    • Trusted single-chip boot with integrated flash
    • Unique device secret (UDS) ensuring distinct device identity
    • Integrated non-volatile configuration memory and user flash memory (UFM) with flexible partitioning and secure locking
    • Comprehensive locking control of programming interface (SPI, JTAG), providing complete protection
    • Side Channel Attack (SCA) resiliency and NIST Cryptographic Algorithm Validation Program (CAVP) compliant algorithms

Lattice also expanded its RoT-enabled Lattice MachXO5-NX device family with new MachXO5-NX TD devices that offer new density and package options. These new Lattice MachXO5-NX TDQ and MachXO5-NX TD FPGA devices are available and have shipped to industry-leading Communications and Compute customers, and are supported by the latest release of Lattice Radiant™ design software.

Experience Lattice PQC-Ready Innovation at OCP Global Summit

Lattice will showcase live demonstrations of its latest FPGA solutions including the MachXO5-NX TDQ for secure, AI-optimized datacenter infrastructure at the OCP Global Summit, taking place Oct. 14–16, 2025 at the San Jose Convention Center, San Jose, Calif. Visit Lattice at Booth #A23 to experience future-ready security, including CNSA 2.0-compliant PQC, intelligent connectivity, and power-efficient AI acceleration.

Supporting Resources

About Lattice Semiconductor

Lattice Semiconductor (NASDAQ: LSCC) is the low power programmable leader. We solve customer problems across the network, from the Edge to the Cloud, in the growing Communications, Computing, Industrial, Automotive, and Consumer markets. Our technology, long-standing relationships, and commitment to world-class support let our customers quickly and easily unleash their innovation to create a smart, secure, and connected world.

For more information about Lattice, please visit www.latticesemi.com. You can also follow us via LinkedIn, X, Facebook, YouTube, WeChat, or Weibo.

Lattice Semiconductor Corporation, Lattice Semiconductor (& design), and specific product designations are either registered trademarks or trademarks of Lattice Semiconductor Corporation or its subsidiaries in the United States and/or other countries. The use of the word “partner” does not imply a legal partnership between Lattice and any other entity.

GENERAL NOTICE: Other product names used in this publication are for identification purposes only and may be trademarks of their respective holders.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251013522544/en/

Contacts

MEDIA CONTACT:
Sophia Hong
Lattice Semiconductor
503-268-8786
Sophia.Hong@latticesemi.com

INVESTOR CONTACT:
Rick Muscha
Lattice Semiconductor
408-826-6000
Rick.Muscha@latticesemi.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 14:00:00 EET | Press release

Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships Powering the Summit CoMotion GLOBAL 2025 is hosted by the Saudi Conventions & Exhibitions General Authority (SCEGA), supported by key Saudi

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67 th American Society of Hematology (ASH) Annual Meeting6.12.2025 16:30:00 EET | Press release

Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which Ono obtained exclusive global rights for the development and commercialization of sapablursen. “In the treatment of PV, phlebotomy and cytoreductive therapy are performed as treatments for preventing thrombosis. Phlebotomy is the most common treatment for PV, in which blood

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 16:30:00 EET | Press release

Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition. These findings further reinforce rusfertide’s efficacy and safety and demonstrate durability of response, with 61.9% of patients continuously treated with rusfertide maintaining absence of phlebotomy eligibility from baseline to Week 52. “The 52-week data demonstrated the sustained efficacy of rusfertide, reducing the need for patients to receive phlebotomy while maintaining hematocrit control,” said Dr. Andrew T. Kuykendall, M.D., VERIFY Lead Investigator and Associate Member in the Department of Hematology at Moffitt Cancer Center. “The 32-week VERIFY primary results were already promising, and this deeper understanding of the durability of r

Vertex Presents New Data on CASGEVY ® , Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 14:01:00 EET | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and TDT ages 12 years and older, will be presented at the American Society of Hematology (ASH) Annual Meeting. CASGEVY is currently approved for eligible people ages 12 years and older with SCD or TDT in the United States, Great Britain, the European Union, the Kingdom of Saudi Arabia, the Kingdom of Bahrain, Kuwait, Qatar, Canada, Switzerland and the United Arab Emirates. “These results — the first clinical data ever presented on any genetic therapy for children ages 5-11 years with SCD — again demonstrate the tr

Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 13:31:00 EET | Press release

The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye